Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Larsson

Showing results (131-140 of 158) with videos related to

Pageof 16
Sort By:
Respiratory Physiology & Neurobiology|May 16, 2017
The effect of exhalation flow on endogenous particle emission and phospholipid compositionPer Larsson, Björn Bake, Anita Wallin, et al.
JAMA Dermatology|April 14, 2021
Long-term Outcomes and Prognosis in New-Onset PsoriasisAxel Svedbom, Lotus Mallbris, Per Larsson, et al.
Cancer Letters|December 14, 2005
Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumoursCharlotta Ryk, Rajiv Kumar, Somali Sanyal, et al.
Human Reproduction (Oxford, England)|April 22, 2022
A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocolManuel Fernández Sánchez, Hana Višnová, Per Larsson, et al.
The Journal of Physical Chemistry. B|November 2, 2017
Characterization of Solubilizing Nanoaggregates Present in Different Versions of Simulated Intestinal FluidAndrew J Clulow, Albin Parrow, Adrian Hawley, et al.
British Journal of Pharmacology|May 25, 2026
Identification of drug repurposing candidates for the treatment of polycystic kidney diseaseAlina Meyer, Paraskevi Sotiropoulou, Koussai Bouker, et al.
Plos One|August 7, 2025
Changes in the pulmonary surfactant in patients with mild to moderate COVID-19Spela Kokelj, Per Larsson, Emilia Viklund, et al.
Scandinavian Journal of Urology and Nephrology|October 25, 2006
Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancerPetra J Berggren de Verdier, Rajiv Kumar, Jan Adolfsson, et al.
RMD Open|January 29, 2016
A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remissionKaterina Chatzidionysiou, Carl Turesson, Annika Teleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCRPetra Berggren, Rajiv Kumar, Shigeru Sakano, et al.
Pageof 16

Showing results (131-140 of 158) with videos related to

Sort By:
Pageof 16
Respiratory Physiology & Neurobiology|May 16, 2017
The effect of exhalation flow on endogenous particle emission and phospholipid compositionPer Larsson, Björn Bake, Anita Wallin, et al.
JAMA Dermatology|April 14, 2021
Long-term Outcomes and Prognosis in New-Onset PsoriasisAxel Svedbom, Lotus Mallbris, Per Larsson, et al.
Cancer Letters|December 14, 2005
Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumoursCharlotta Ryk, Rajiv Kumar, Somali Sanyal, et al.
Human Reproduction (Oxford, England)|April 22, 2022
A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocolManuel Fernández Sánchez, Hana Višnová, Per Larsson, et al.
The Journal of Physical Chemistry. B|November 2, 2017
Characterization of Solubilizing Nanoaggregates Present in Different Versions of Simulated Intestinal FluidAndrew J Clulow, Albin Parrow, Adrian Hawley, et al.
British Journal of Pharmacology|May 25, 2026
Identification of drug repurposing candidates for the treatment of polycystic kidney diseaseAlina Meyer, Paraskevi Sotiropoulou, Koussai Bouker, et al.
Plos One|August 7, 2025
Changes in the pulmonary surfactant in patients with mild to moderate COVID-19Spela Kokelj, Per Larsson, Emilia Viklund, et al.
Scandinavian Journal of Urology and Nephrology|October 25, 2006
Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancerPetra J Berggren de Verdier, Rajiv Kumar, Jan Adolfsson, et al.
RMD Open|January 29, 2016
A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remissionKaterina Chatzidionysiou, Carl Turesson, Annika Teleman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCRPetra Berggren, Rajiv Kumar, Shigeru Sakano, et al.
Pageof 16